Stock Splits
By The Online Investor Staff, updated Tue., Aug. 14, 10:51 PM
| This Slide: #1 of 25 |
Slide #1. Synthetic Biologics, Inc. (AMEX:SYN) — 1 for 35 Reverse Split
Announced:
8/1/2018
Stock Split:
1 for 35
Record Date:
8/10/2018
Pay Date:
8/13/2018
SYN Optionable?:
No
Synthetic Biologics is a clinical company focused on developing therapeutics designed to keep the microbiome. Co.'s key candidates in Phase 3 development are: SYN-004 (ribaxamase) which is designed to protect the gut microbiome from the effects of certain intravenous beta-lactam antibiotics for the prevention of C. difficile infection, overgrowth of pathogenic organisms and the emergence of antimicrobial resistance; and SYN-010, which is intended to reduce the effect of methane-producing organisms in the gut microbiome. Co. is developing preclinical stage monoclonal antibody therapies for the prevention and treatment of pertussis, and biotherapeutics for the treatment of phenylketonuria. 
SYN Detailed Information Page & Split History »
|
|||||||||||||||||||||
Open the SYN Page at The Online Investor (in a new window) »
List of Stock Splits in this Slideshow: Ticker Stock Split Announced Record Date Pay Date Optionable FXP 1 for 4 5/9/2018 5/23/2018 5/24/2018 Yes SSG 1 for 2 5/9/2018 5/23/2018 5/24/2018 Yes ZBIO 1 for 2 5/9/2018 5/23/2018 5/24/2018 Yes SEF 1 for 2 5/9/2018 5/23/2018 5/24/2018 Yes SMN 1 for 2 5/9/2018 5/23/2018 5/24/2018 Yes JCTCF 2 for 1 5/9/2018 5/22/2018 5/25/2018 No BIOL 1 for 5 5/10/2018 5/10/2018 5/11/2018 No EXPO 2 for 1 5/15/2018 5/31/2018 6/1/2018 Yes HBNC 3 for 2 5/16/2018 6/15/2018 6/18/2018 Yes PFBI 5 for 4 5/22/2018 6/4/2018 6/15/2018 No CRIS 1 for 5 5/22/2018 5/29/2018 5/30/2018 Yes ACHV 1 for 10 5/23/2018 5/23/2018 5/24/2018 No FCSC 1 for 5 5/24/2018 5/24/2018 5/25/2018 Yes CTRV 1 for 8 5/24/2018 5/24/2018 5/25/2018 No IBIO 1 for 10 5/31/2018 6/8/2018 6/11/2018 No EXPO 2 for 1 5/31/2018 5/31/2018 6/7/2018 Yes TROV 1 for 12 5/31/2018 6/1/2018 6/4/2018 Yes GEVO 1 for 20 6/1/2018 6/1/2018 6/4/2018 Yes JAGX 1 for 15 6/1/2018 6/1/2018 6/1/2018 No RSLS 1 for 15 6/1/2018 6/1/2018 6/4/2018 No TMSR 2 for 1 6/4/2018 6/4/2018 6/20/2018 No DOL.CA 3 for 1 6/7/2018 6/14/2018 6/19/2018 No FEC.CA 2 for 1 6/11/2018 6/21/2018 6/26/2018 No IDRA 1 for 8 7/27/2018 7/27/2018 7/30/2018 Yes SYN 1 for 35 8/1/2018 8/10/2018 8/13/2018 No
|
|
Avg. Broker Rec.
 
|
Buy (3.33 out of 4) 54th percentile
(ranked higher than approx. 54% of all stocks covered)
Based on Zacks ABR data; powered by Xignite |
